These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25426067)

  • 21. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?
    Crum J; Wilson J; Sabbagh M
    Alzheimers Res Ther; 2018 Oct; 10(1):104. PubMed ID: 30285877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta ; Birks J
    Cochrane Database Syst Rev; 2001; (1):CD000147. PubMed ID: 11279679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
    Fioravanti M; Flicker L
    Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.
    Hajjar I; Schumpert J; Hirth V; Wieland D; Eleazer GP
    J Gerontol A Biol Sci Med Sci; 2002 Jul; 57(7):M414-8. PubMed ID: 12084801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
    Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
    Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galantamine for vascular cognitive impairment.
    Birks J; Craig D
    Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual Impairment, Eye Diseases, and Dementia Risk: A Systematic Review and Meta-Analysis.
    Kuźma E; Littlejohns TJ; Khawaja AP; Llewellyn DJ; Ukoumunne OC; Thiem U
    J Alzheimers Dis; 2021; 83(3):1073-1087. PubMed ID: 34397414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual impairment and cognitive dysfunction in Alzheimer's disease.
    Uhlmann RF; Larson EB; Koepsell TD; Rees TS; Duckert LG
    J Gen Intern Med; 1991; 6(2):126-32. PubMed ID: 2023019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2000; 2002(2):CD000147. PubMed ID: 10796495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple Neuropsychological Tests May Identify Participants in Whom Aspirin Use Is Associated With Lower Dementia Incidence: The Canadian Study of Health and Aging.
    Oveisgharan S; Hachinski V
    Am J Alzheimers Dis Other Demen; 2016 Nov; 31(7):545-550. PubMed ID: 26705378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binocular Vision, Visual Function, and Pupil Dynamics in People Living With Dementia and Their Relation to the Rate of Cognitive Decline and Structural Changes Within the Brain: Protocol for an Observational Study.
    Piano M; Nilforooshan R; Evans S
    JMIR Res Protoc; 2020 Aug; 9(8):e16089. PubMed ID: 32773379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home.
    Mandas A; Congiu MG; Abete C; Dessi S; Manconi PE; Musio M; Columbu S; Racugno W
    Neurol Res; 2014 Mar; 36(3):247-54. PubMed ID: 24512018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer and vascular dementias and driving. A prospective road and laboratory study.
    Fitten LJ; Perryman KM; Wilkinson CJ; Little RJ; Burns MM; Pachana N; Mervis JR; Malmgren R; Siembieda DW; Ganzell S
    JAMA; 1995 May; 273(17):1360-5. PubMed ID: 7715061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galantamine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004746. PubMed ID: 16437493
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.